Fundraising Fox

Aledade

Unicorn · $3.5B

Bethesda, US · Founded 2014 · Delaware corporation · 16 known investors

aledade.com

Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality. The company operates as a public benefit corporation focused on supporting member primary care organizations and their patients.

Also known as Aledade, Inc.

Enterprise SoftwareHealthtech

Founders & leadership

Aledade was founded in 2014 by Bijan Salehizadeh, Farzad Mostashari, and Mat Kendall.

BSBijan Salehizadeh
Bijan SalehizadehCo-founder
FMFarzad Mostashari
Farzad Mostashariin𝕏Founder & CEOBefore starting Aledade in 2014, he served as National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services and, earlier, as Deputy National Coordinator at ONC. His earlier career included work as an assistant commissioner at the New York City Department of Health and Mental Hygiene, an EIS officer at the CDC, a medical residency at Massachusetts General Hospital, and a visiting fellowship at the Brookings Institution.
MKMat Kendall
Mat Kendallin𝕏Co-founder and PresidentHe co-founded Aledade in 2014 and previously led provider networks there as executive vice president. His earlier roles include director of the Office of Provider Adoption Support at the Office of the National Coordinator for Health Information Technology, director of operations for the Primary Care Information Project at the New York City Department of Health and Mental Hygiene, and executive director of the Indian Health Center of Santa Clara Valley.
SB
Stephen B. ThauNamed on SEC filing

Board

RKRobert Kocher
Robert Kocherin𝕏Board directorPartner at Venrock

Investors · 16

Also in the syndicate · 4

Avidity PartnersCalifornia Medical AssociationFidelity Management & Research CompanyOMERS Growth Equity

Reported raises · per SEC filings

Form D private placements

$662.6M disclosed across 8 of 13 rounds · 2014–2025

$260MraisedJun 2023 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Phuong PhillipsExecutive Officer
  • Michelle RyanDirector
  • John DoyleExecutive Officer
  • Paul HennessyDirector
  • Farzad MostashariExecutive Officer, Director
  • David BlumenthalDirector
  • Robert KocherDirector
  • Phyllis YaleDirector
  • Julie SunderlandDirector
  • Bijan SalehizadehDirector
  • Matthew KendallExecutive Officer
Offering amount
$260M
Amount sold
$260M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$122.3MraisedJun 2022 · 20 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Farzad MostashariExecutive Officer, Director
  • Kendall MatExecutive Officer
  • Bijan SalehizadehDirector
  • John DoyleExecutive Officer
  • Julie SunderlandDirector
  • Phyllis YaleDirector
  • Michelle RyanDirector
  • Robert KocherDirector
Offering amount
$122.3M
Amount sold
$122.3M
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100MraisedJan 2021 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mat KendallExecutive Officer
  • James ManziDirector
  • Julie SunderlandDirector
  • Farzad MostashariExecutive Officer, Director
  • Robert KocherDirector
Offering amount
$100M
Amount sold
$100M
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$64.4MraisedApr 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Farzad MostashariExecutive Officer, Director
  • Charles ColliganExecutive Officer
  • James ManziDirector
  • Patrick ConwayDirector
  • Julie SunderlandDirector
  • Robert KocherDirector
Offering amount
$77.2M
Amount sold
$64.4M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$56.1MraisedJan 2019 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie SunderlandDirector
  • Farzad MostashariExecutive Officer, Director
  • Charles ColliganExecutive Officer
  • Robert KocherDirector
  • James ManziDirector
Offering amount
$56.1M
Amount sold
$56.1M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$40.2MraisedMar 2017 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert KocherDirector
  • Mark McClellanDirector
  • Stephen B. ThauExecutive Officer
  • Farzad MostashariExecutive Officer, Director
  • Julie SunderlandDirector
Offering amount
$40.2M
Amount sold
$40.2M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15MraisedJun 2015 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert KocherDirector
  • Farzad MostashariExecutive Officer, Director
Offering amount
$30M
Amount sold
$15M
First sale
May 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4.5MraisedJun 2014 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert KocherDirector
  • Farzad MostashariExecutive Officer, Director
  • Stephen B. ThauExecutive Officer
Offering amount
$5.5M
Amount sold
$4.5M
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$3.5Bvaluation at Series FJun 2023
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Company profile

researched Aug 2026

Aledade is a Bethesda, Maryland-based health care technology company that organizes and operates accountable care organizations (ACOs) for primary care organizations, including independent practices, community health centers and health systems. It supplies data analytics, software, workflow tools, coaching and administrative support so that clinicians can adopt value-based care while remaining independent, and it holds contracts with Medicare, Medicaid and commercial payers under which participating practices earn shared savings.

The company's offerings are grouped into a technology platform that centralizes and surfaces patient data at the point of care, expert support and coaching, practice resources covering contracting and financial/operational support, and patient engagement solutions. Additional programs include Aledade FIRST, a value-based care curriculum for PGY2 and PGY3 primary care residents that includes subsidized clinical rotations, job placement with partner practices and financial incentives of up to $60,000 aligned with loan-forgiveness programs; a turnkey program in select states to help clinicians start an independent practice; and the Aledade Policy Institute, which conducts state and national policy advocacy. Aledade Access is a Medicare-covered, physician-referred remote monitoring and coaching program for patients with high blood pressure, high cholesterol, high blood sugar or early kidney disease that provides a connected blood pressure cuff at no cost to the patient; participation is tied to a federal payment model test run by CMS in which some beneficiaries are randomly assigned to a comparison group.

Aledade is structured as a public benefit corporation and describes itself as the largest network of independent primary care practices in the United States. A third-party profile also notes integrations with over 100 EHRs and more than 300 external data sources.

Founding story

Aledade was founded in 2014 on the premise that value-based primary care can be scaled by giving primary care accountability for total cost and quality of care, according to co-founder and CEO Farzad Mostashari. A third-party profile states it was founded by Farzad Mostashari, Mat Kendall and Edwin Miller, and that Mostashari, formerly head of the Office of the National Coordinator for Health Information Technology at HHS, started the company with seed funding from Venrock after concluding that small independent primary care physicians were well positioned for value-based care but lacked tools and support.

Business model

Aledade contracts with payers on behalf of networks of primary care organizations and shares in the savings generated when those practices reduce total cost of care while meeting quality targets; the company states its model succeeds only when its practices succeed. Practices retain ownership and independence rather than being acquired.

Revenue is derived from value-based care contracts with Medicare (including the Medicare Shared Savings Program), Medicare Advantage plans, Medicaid and commercial payers, with shared savings distributed to participating practices. Reported revenue exceeded $475 million for 2022, more than 50% growth over 2021.

Traction

As of the current website, more than 3,000 primary care partners across 46 states and D.C. and more than 3 million lives under management, with 84% of decision-makers rating its products and services as high quality in a 2025 customer experience survey. At the time of the 2023 Series F, the network covered more than 1,500 practices in 45 states and D.C., more than 150 value-based care contracts covering over two million patients and more than $20 billion in total health care spending, including more than one million Medicare Shared Savings Program patients and nearly 250,000 Medicare Advantage patients, with more than $1.7 billion in cumulative savings to the U.S. health care system through 2022.

Latest developments

The company has announced the hiring of a new chief technology officer and a chief scientist to accelerate AI innovation, published a case study on community hypertension management, and is running the Aledade Access remote monitoring program tied to a CMS payment model test. A third-party profile lists a $500 million debt financing announced in December 2025.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Aledade describes itself as the largest network of independent primary care practices in the U.S. A third-party profile states that in 2023, 93% of its ACO partners earned shared savings versus a 70% national average, that five of the top 10 Medicare Shared Savings Program ACOs are Aledade affiliates, that Newsweek named it among the World's Best Digital Health Companies in 2024 for medical management, and that Forbes ranked it No. 3 among U.S. healthcare startups.

Physician-led ACO model that lets practices access data, technology and scale without selling their practice; multiple ACO track options; contracts spanning Medicare and commercial insurers rather than Medicare alone; and reported partner outcomes such as 50% more Annual Wellness Visits than the average practice in 2023 and average shared savings payments above $205,000 per partner in 2023.

Technology

A technology platform that captures, centralizes and surfaces actionable patient data at the point of care to support earlier clinical intervention and care coordination, with tooling to identify at-risk patients and close care gaps. A third-party profile describes integrations with more than 100 EHRs and over 300 external data sources. The company has announced new CTO and chief scientist appointments to accelerate AI innovation and describes providing AI tools to partner organizations. The Aledade Access program uses connected 'smart' blood pressure cuffs that transmit readings to the patient's physician, paired with SMS/phone-based health coaching.

Go-to-market

Direct partnership recruitment of primary care organizations into regional Aledade ACOs across 46 states and D.C., supported by state-level ACO options, partner spotlight case studies, a residency pipeline program (Aledade FIRST) and alliances with national and regional health plans.

Independent primary care practices, community health centers, health systems and clinics; downstream beneficiaries are their patients, including Medicare and Medicare Advantage members.

Geography

United States; headquartered in Bethesda, Maryland, with partner primary care organizations in 46 states and the District of Columbia (45 states and D.C. as of 2023).

History

Founded in 2014, Aledade raised successive venture rounds from 2014 through 2023 and grew its ACO network nationally. A third-party profile reports the 2022 acquisition of Iris Healthcare to add advance care planning to its platform, a 10-year Medicare Advantage primary care partnership with Humana, and a $3.5 billion valuation following the June 2023 $260 million Series F led by Lightspeed Venture Partners. In 2023 the company added David Blumenthal and Paul Hennessy to its board and hired Efrem Castillo as SVP for Medicare Advantage, while Mandy Cohen, then CEO of Aledade Care Solutions, left to become director of the CDC.

Risks & controversies

No controversies are described in the available sources. Sources note dependence on federal programs and CMS model design (for example, Aledade Access enrollment is limited by CMS randomized comparison-group assignment), and third-party data on scale, funding totals and valuation is inconsistent with company-reported figures.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
ACO partners earning shared savingsJan 202393%
Annual Wellness Visits vs. average practiceJan 202350%
Average shared savings payment per partnerJan 2023$205K
Cumulative savings to U.S. health care systemJan 2022$1.7B
EmployeesJan 202510,000 employees
Independent primary care practices in networkJan 20231,500 practices
Lives under managementJan 20253,000,000 patients
Partners rating products and services as high qualityJan 202584%
Patients under Medicare Advantage contractsJan 2023250,000 patients
Patients under Medicare Shared Savings ProgramJan 20231,000,000 patients
Primary care partner organizationsJan 20253,000 organizations
RevenueJan 2022$475M
States coveredJan 202546 states
Total funding raisedJan 2025$1.2B
Total health care spending under contractJan 2023$20B
ValuationJan 2023$3.5B

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 6

by search overlap
Definitive Healthcare591 shared keywordsDefinitive Healthcare provides a healthcare commercial intelligence platform with all-payor claims data, reference data, and analytics on hospitals, physicians, payors, procedures, diagnoses, and prescriptions. It serves life sciences companies, healthcare providers, and healthcare-adjacent businesses for market analysis, targeting, and sales and marketing efforts, with an AI-powered intelligence product announced for Winter 2026.
ChartSpan549 shared keywordsChartSpan provides managed care services, including Chronic Care Management and Remote Patient Monitoring, to help healthcare providers run value-based care programs. Following its acquisition of Validic, the company also offers device and data infrastructure for data-driven clinical services.
Elation430 shared keywordsElation Health builds health technology for independent primary care practices and physicians, centered on the physician-patient relationship. Its products support practice workflows, operations, and value-based care.
Clinii371 shared keywordsClinii is an AI-powered chronic care management platform that helps healthcare providers document, track, and bill Medicare care programs such as CCM, PCM, RPM, and BHI. It integrates with 30+ EHRs and serves providers ranging from solo practices to value-based care networks in the US.
Aha367 shared keywordsContent references the American Hospital Association's national advisory work on cybersecurity and risk for the U.S. healthcare field, including analysis of cyberattacks targeting hospitals and health systems.
HealthArc351 shared keywordsHealthArc provides a platform for Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), serving hospitals and healthcare providers. The company focuses on optimizing clinical workflows and supporting data-driven healthcare management.

Companies competing with Aledade for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 10

launches, deals, and filings
Dec 2025
$500 million debt financing

A third-party profile lists a $500 million debt financing announced in December 2025.

$500M source ↗

Jan 2025
New CTO and chief scientist appointed to accelerate AI innovation

Aledade announced the addition of a chief technology officer and chief scientist to accelerate AI innovation.

source ↗

Jan 2025
Aledade Access patient support program

Physician-referred, Medicare-covered program providing a free connected blood pressure cuff, health coaching and data sharing with the patient's physician for conditions including hypertension, high cholesterol, diabetes/pre-diabetes and early kidney disease; operated in connection with a CMS payment model test.

source ↗

Jan 2024
Named to Newsweek's World's Best Digital Health Companies for medical management

Third-party profile reports Newsweek recognition in 2024 and a No. 3 Forbes ranking among U.S. healthcare startups.

source ↗

Jun 2023
Aledade closes $260 million Series F led by Lightspeed Venture Partners

Aledade announced a $260 million Series F round to accelerate network growth, enhance technology and pursue strategic acquisitions, with participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management & Research Company.

$260M source ↗

Jun 2023
David Blumenthal and Paul Hennessy join board of directors

Aledade added David Blumenthal, M.D., former president of the Commonwealth Fund and former U.S. National Coordinator for Health Information Technology, and Paul Hennessy, CEO of Shutterstock, to its board.

source ↗

Jun 2023
Efrem Castillo appointed SVP for Medicare Advantage

Efrem Castillo, M.D., previously SVP of clinical transformation at Optum and CMO at UnitedHealthcare Medicare Solutions, joined Aledade as senior vice president for Medicare Advantage.

source ↗

Jun 2023
Mandy Cohen departs as CEO of Aledade Care Solutions

Mandy Cohen, M.D., M.P.H., CEO of Aledade Care Solutions, left the company to become director of the Centers for Disease Control and Prevention.

source ↗

Jan 2023
10-year Medicare Advantage partnership with Humana

A third-party profile reports a 10-year agreement with Humana covering Medicare Advantage primary care.

source ↗

Jan 2022
Acquisition of Iris Healthcare

Aledade acquired Iris Healthcare to integrate advance care planning into its platform, according to a third-party company profile.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
AledadeDelaware

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Aledade do?
Physician-led value-based care company that builds and operates accountable care organizations with independent primary care practices.
Who founded Aledade?
Aledade was founded by Bijan Salehizadeh, Farzad Mostashari, Mat Kendall in 2014.
Who are Aledade's investors?
Aledade's investors include Activate Venture Partners, ARCH Venture Partners, Echo Health Ventures, GV (Google Ventures), Intrepid Growth Partners, IVP (Institutional Venture Partners), Lightspeed Venture Partners, McKesson Ventures and 4 more.
How much funding has Aledade raised?
Aledade has disclosed $662.6M raised across 8 of its 13 known rounds.
Where is Aledade headquartered?
Aledade is headquartered in Bethesda, US.